Data gathered: December 9
AI Stock Analysis - Bioventus (BVS)
Analysis generated December 8, 2024. Powered by Chat GPT.
Bioventus Inc. is a global leader in orthobiologics and the development of innovative products aimed at minimizing pain, healing bone fractures, and providing clinically proven and cost-effective treatments for patients. The company focuses on active healing and pre-surgical therapy products aimed at improving patient outcomes and enhancing the quality of life. Bioventus' market presence and specialized niche position it as a key player in the orthobiologics market.
Stock Alerts - Bioventus (BVS)
 |
Bioventus | December 5 Price is up by 5.3% in the last 24h. |
|
Bioventus | December 4 Price is down by -5.5% in the last 24h. |
|
Bioventus | December 3 Employee Rating is up by 5.4% over the last month. |
|
Bioventus | December 3 Business Outlook among employees is up by 10.5% over the last month. |
Alternative Data for Bioventus
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 35 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 11,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | 31 | Sign up | Sign up | Sign up |
| Patents | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 626 | Sign up | Sign up | Sign up |
| Instagram Followers | 651 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 420 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,867 | Sign up | Sign up | Sign up |
| Twitter Mentions | 7 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 24,600 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 73 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,226 | Sign up | Sign up | Sign up |
About Bioventus
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body’s natural healing process in the United States and internationally.
| Price | $11.10 |
| Target Price | Sign up |
| Volume | 234,810 |
| Market Cap | $763M |
| Year Range | $3.96 - $13.71 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Medical Devices |
In the news
 |
MetLife Investment Management LLC Purchases 12,949 Shares of Bioventus Inc. (NYSE:BVS)December 9 - ETF Daily News |
|
Intech Investment Management LLC Invests $167,000 in Bioventus Inc. (NYSE:BVS)December 7 - ETF Daily News |
 |
Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a BetDecember 5 - Yahoo |
|
GSA Capital Partners LLP Has $703,000 Stake in Bioventus Inc. (NYSE:BVS)November 18 - ETF Daily News |
 |
Q3 2024 Bioventus Inc Earnings CallNovember 5 - Yahoo |
 |
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...November 5 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 139M | 131M | 94M | -4.8M | 6.1M | 0.060 |
| Q2 '24 | 151M | 176M | 104M | -24M | -27M | 0.190 |
| Q1 '24 | 129M | 121M | 88M | -4.6M | -1.7M | 0.070 |
| Q4 '23 | 135M | 130M | 86M | -6.1M | -4.5M | 0.070 |
| Q3 '23 | 118M | 114M | 79M | -7.3M | -4.2M | 0.050 |
Insider Transactions View All
| Bartholdson John A. filed to buy 6,939,357 shares at $8.5. August 20 '24 |
| Bartholdson John A. filed to buy 6,913,857 shares at $8.5. August 20 '24 |
| CHURCH KATRINA J filed to sell 41,199 shares at $5.6. June 25 '24 |
| D'Adamio Anthony filed to sell 95,576 shares at $5.6. June 25 '24 |
| Singleton Mark Leonard filed to sell 84,895 shares at $5.6. June 25 '24 |
Similar companies
Read more about Bioventus (BVS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bioventus?
The Market Cap of Bioventus is $763M.
What is the current stock price of Bioventus?
Currently, the price of one share of Bioventus stock is $11.10.
How can I analyze the BVS stock price chart for investment decisions?
The BVS stock price chart above provides a comprehensive visual representation of Bioventus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bioventus shares. Our platform offers an up-to-date BVS stock price chart, along with technical data analysis and alternative data insights.
Does BVS offer dividends to its shareholders?
As of our latest update, Bioventus (BVS) does not offer dividends to its shareholders. Investors interested in Bioventus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bioventus?
Some of the similar stocks of Bioventus are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.